SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009675
Filing Date
2024-07-05
Accepted
2024-07-05 16:30:18
Documents
15
Period of Report
2024-07-02
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20240702x8k.htm   iXBRL 8-K 32471
  Complete submission text file 0001558370-24-009675.txt   193726

Data Files

Seq Description Document Type Size
2 EX-101.SCH pmn-20240702.xsd EX-101.SCH 4365
3 EX-101.DEF pmn-20240702_def.xml EX-101.DEF 2871
4 EX-101.LAB pmn-20240702_lab.xml EX-101.LAB 12906
5 EX-101.PRE pmn-20240702_pre.xml EX-101.PRE 12253
17 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20240702x8k_htm.xml XML 4994
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 241102874
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)